Search Results for '
Financial Reports: Biogen Idec'
Refine by Dates:
Refine By Content:
All Advanced Degrees Ask The Board Ask The Experts Back Page Bio News & Views Breaking News Business Corner Buyers Guide Companies Cartoons Case Studies Classifieds Collaborations & Alliances Columns Conference Sessions Contracting & Outsourcing CRO News Custom Sourcing News Editorial Executive Perspective Expert's Opinion FDA Watch Features Financial Analysis Financial Reports Getting Results Glossary I Mak India Report Industry Events Industry News Jobs Literature / Brochures Lowe Down Managing Your Careeer News Releases Online Exclusives Outsourcing Survey Packaging & Tracking Pharma Beat Podcasts Posters Preclinical Outsourcing Product Releases Promotions & Movies Provider Survey Salary Survey Services Slideshows Top Companies Report Trials & Filings Videos Webinars White Papers / Tech Papers
By Gil Roth
Published January 28, 2013
Published February 16, 2006
4Q Revenues: $633 million (+8%)
4Q Earnings: $56 million (+94%)
FY Revenues: $2.4 billion (+10%)
FY Earnings: $161 million (+541%)
Comments: Revenues for the quarter and full year were driven by Rituxan and Avonex. R…
Read More »
Please visit our sister sites: